Related Experiment Video
Updated: Sep 5, 2025

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
619
Does three-dimensional intraglandular location predict malignancy in parotid tumors?
S J Lohmeier1, R E Heidel2, B L Hechler3
1Department of Oral and Maxillofacial Surgery, San Antonio Military Health System, San Antonio, TX, USA.
Summary
Parotid tumors anterior to the retromandibular vein are more likely malignant. Increasing age and local pain also indicate a higher risk of parotid cancer.
Area of Science:
- Otolaryngology
- Head and Neck Surgery
- Oncology
Background:
- Parotid tumors present a diverse range of benign and malignant conditions.
- Accurate diagnosis and risk stratification are crucial for effective patient management.
Purpose of the Study:
- To investigate the correlation between the anatomical location of intraparotid masses and the likelihood of malignancy.
- To identify key factors aiding in the preoperative assessment of parotid tumor malignancy risk.
Main Methods:
- Retrospective cohort study of patients undergoing open parotid tumor excision.
- Tumor location determined via preoperative imaging; analyzed demographic, clinical, and radiographic data.
- Statistical analysis included chi-squared tests and stepwise logistic regression.
Main Results:
- Older age and the presence of local pain were significantly associated with malignancy.
- Tumors located anterior to the retromandibular vein's posterior border showed a 2.18-fold increased odds of malignancy.
- Multivariate analysis confirmed age, pain, and specific anterosuperior/superoinferior locations as predictors of malignancy.
Conclusions:
- Tumor location within the parotid gland, particularly anterior to the retromandibular vein, is a significant predictor of malignancy.
- Patient age and the presence of pain are also valuable indicators for assessing malignancy risk.
- Integrating these factors into preoperative assessments can improve diagnostic accuracy for parotid tumors.

